Právní předpis byl sestaven k datu 25.10.2018.
Zobrazené znění právního předpisu je účinné od 25.10.2018 do 02.06.2021.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
463
XXXXXXXX XXXXX
xx xxx 18. prosince 2013
x xxxxxxxxx xxxxxxxxxx látek
Vláda xxxxxxxx xxxxx §44c xxxx. 1 zákona x. 167/1998 Sb., x xxxxxxxxxx xxxxxxx x o xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx zákona x. 273/2013 Xx.:
§1
Toto nařízení xxxxxxx
x) x příloze č. 1 x xxxxxx xxxxxxxx seznam
1. xxxxxxxx xxxxx zařazených xx Xxxxxxx X xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx1) x
2. dalších xxxxxxxx xxxxx, x xxxxx xx x důvodu xxxxxxx xxxxxx zneužívání xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx zdraví, nezbytné xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx x xxxxxxxxx, nebo xx z xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxx x xxxxxxx xxxxx xx xxxxxx nebo xxxxxxx označené xxxxxx xxxxxx xxxxxxxxxx x xxxxxx xxxxxxx rohu xx xxxxxxx horního xxxx,
(xxxx xxx "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) x příloze č. 2 x tomuto nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, u xxxxx je z xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx proto, xx bezprostředně xxxx xxxxxxx xxxxxxxx zdraví, xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx xxxx omamné xxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxx xxxx žádanku xxx xxxxxxxx modrým pruhem,
(dále xxx "xxxxxx x. 2 omamných látek"),
c) x příloze č. 3 k xxxxxx nařízení xxxxxx
1. xxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx XX xxxxx Xxxxxxxx xxxxxx x omamných xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x nichž xx x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx proto, že xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxx x xxxxxxxxx obsahující xxxx xxxxxx látky xxxx používány pouze x xxxxxxxx výzkumným, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx xxxxxxxxx x xxxxxxxx x xxxxxxxxx,
(xxxx jen "xxxxxx č. 3 xxxxxxxx xxxxx"),
x) x příloze č. 4 x tomuto xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx X podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. xxxxxxx xxxxxxxxxxxxxx látek, x xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx zabezpečit, aby xxxxx x xxxxxxxxx xxxxxxxxxx tyto psychotropní xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx a xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxx vymezeným x xxxxxxxx k xxxxxxxxx,
(xxxx xxx "xxxxxx č. 4 psychotropních látek"),
e) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx psychotropních xxxxx, x nimiž xx x důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx k xxxxxxxxx, xxxx xx x xxxxxx xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx přípravky obsahující xxxx xxxxxxxxxxxx xxxxx xxxx vydávány x xxxxxxx xxxxx xx xxxxxx xxxx žádanku xxxxxxxx modrým pruhem xxxxxxxxxx z xxxxxx xxxxxxx xxxx do xxxxxxx horního rohu,
(dále xxx "xxxxxx č. 5 xxxxxxxxxxxxxx látek"),
f) x příloze č. 6 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxxxx látek zařazených xx Seznamu XXX xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx do Xxxxxxx XX xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. dalších xxxxxxxxxxxxxx xxxxx, u xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují zdraví, xxxxx zabezpečit, xxx xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx recept xxxx xxxxxxx xxx xxxxxxxx xxxxxx pruhem,
(dále jen "xxxxxx č. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 x xxxxxx xxxxxxxx xxxxxx xxxxxxxxx xxxxxxxxxx xx Xxxxxxx XXX podle Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx nařízení xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx 98/34/ES ze xxx 22. xxxxxx 1998 o postupu xxx poskytování informací x xxxxxxx norem x xxxxxxxxxxx předpisů x předpisů pro xxxxxx xxxxxxxxxx xxxxxxxxxxx, x platném znění.
(2) Xxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx předpisy Evropské xxxx xxxxxxxx xx xxxxxxxxxx látek3).
§3
Xxxx nařízení xxxxxx xxxxxxxxx dnem 1. xxxxx 2014.
Xxxxxxx č. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 omamných xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx- 6,14-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
XxxxxX-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxX-2-xxxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx |
|
|
XxxxxXxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4Xx)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
XXxxxxxxxx |
(3X,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xX-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx) xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxXxxx)-4.5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
(3X,6X)-6-{xxxxxxxxxxxxx )-4.4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxX-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxX-4-[4-(2-xxx-3-xxxxxxxxX-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx) piperidino]butannitril |
|
|
Dextromoramid |
1-[(3S)-2,2-difenyl-3-methyl-4-morfolinobutanoyl]pyrrolidin |
|
|
Diampromid |
N-[2-(N-fenethyl-N-methylamono)propyl]propananilid |
|
|
Diethyltriambuten |
3-(diethylamino)-1,1-di(2-thienyl)but-1-en |
|
|
Difenoxin |
1-(3,3-difenyl-3-kyanpropyl-4-fenylpiperidin-4-karhoxylová kyselina |
|
|
Difenoxylát |
ethyl-1-(3,3-difenyl-3-kyanpropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Dihydroetorfin |
(5R,6R,7R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl- 6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx)]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (1X,2X,3X,5X)-3-xxxxxxx-8-xxxxxx-9-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, xxxx xxxxxx a xxxxxxxx, x kterých je xxxxx xxxxxx xxxxxxx x kokain |
|
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
|
Etonitazen |
1-[2-(deethylamino)ethyl]-2-(4-ethoxybenzyl]-5-nitro-1H-benzimidazol |
|
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
|
Fenadaxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano- 3-benzazocin-8-ol |
|
|
Fenomorfan |
17-fenethyImorfinan-3-ol |
|
|
Fenoperidin |
ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát |
|
|
Fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid |
|
|
Furethidin |
ethyI-4-fenyI-1-[2-(furfuryloxy)ethyl]piperidinn-4-karboxylát |
|
|
Hydrokodon |
4,5α-epoxy-3-methoxy-17-rnethyImorfinan-6-on |
|
|
Hydromorfinol |
4,5α-epoxy-17-methylmorfinan-3,6α,14-triol |
|
|
Hydromorfon |
4,5α-epoxy-3-hydroxy-17-rnethylmorfinan-6-on |
|
|
Hydroxypethidin |
ethyl-4-(3-hydroxyfenyl)-1-rnethylpiperidin-4-karboxylát |
|
|
lsomethadon |
6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on |
|
|
Karfentanil |
methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát |
|
|
Klonitazen |
2-(4-chlorbenzyl)-1-[2-(diethylarnino)ethyl]-5-nitro-1H-benzimidazol |
|
|
Kodoxim |
kyselina 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxxx-6-xxxxxx) amino]oxy}octová |
|
|
Koka - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2- xxxxxxxxxx |
|
|
Xxxxxxxxxx x xxxxxxxx |
Xxxxxxxxxxx x xxxxxx alkaloidů xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
|
Xxxxxx xxxxxxx a tinktura |
Extrakt x xxxxxxxx x xxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxx xxxxxx k xxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[(9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx xxxxxxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx omamných xxxxx xxxxxxxxx x xxxx příloze |
|
Levomoramid |
(3R)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Levorfanol |
(9R,13R,14R)-17-methylmorfinan-3-ol |
Stereoizomerní xxxxxxxxxxx [(+)-3-xxxxxxx-17- xxxxxxxxxxxxxx] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx uvedených x xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3- xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, meziprodukt |
4-(dimethylamono)-2,2-difenylpentanitril |
|
|
Methyldesorfin |
4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol |
|
|
Methyldihydromorfin |
4,5-epoxy-6,17-dimethylmorfinan-3,6-diol |
|
|
Metopon |
4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on |
|
|
Moramid, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(3-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxXxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx methobromid |
4,5α-epoxy-3,6α-dihydroxy-17,17-dimethylmorfin-7-en-17-ium-bromid |
a jiné xxxxxxxx xxxxxxx se xxxxxxxxxx xxxxxxx xxxxxx xxxxxxxx morfin-N-oxidu (i xxxxxx-X-xxxxx) |
|
Xxxxxx-X-xxxx |
4,5α -epoxy-17-methylmorfin-7-en-3,6α-diol-17-oxid |
|
|
DesmethyIprodin |
4-fenyl-1-methylpiperidin-4-yl-propanoát |
MPPP |
|
Myrofin |
3-(benzyloxy)-4,5α-epoxy-17-methylmorfin-7-en-6-yl-tetradekanoát |
|
|
Nikomorfin |
4,5α-epoxy-17-methylmorfin-7-en-3,6α-diyl-dinikotinát |
|
|
Noracymethadol |
4,4-difenyl-6-(methylamono)heptan-3-yl-acetát |
|
|
Norlevorfanol |
(9R,13R,14R)-morfinan-3-ol |
|
|
Normethadon |
6-(dimethylamono)-4,4-difenylhexan-3-on |
|
|
Normorfin |
4,5α-epoxymorfin-7-en-3,6α-dioI |
|
|
Norpipanon |
4,4-defenyl-6-piperidinohexan-3-on |
|
|
Opium |
Kromě xxxxxxxxxxxx xxxxxxxxxx přípavků, jejichž xxxxxx xxxxxx xx xxxxx než X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxXxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
4-xxxxx-1-xxxxxxxxxxxxxxx-1-xxxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx X |
xxxxxxxx 4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxx-1-(3-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxx |
1'-(3,3-xxxxxxx-3-xxxxxxxxxx-4'-xxxxxx-1,4'-xxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
4-xxxxx-1,3-xxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxxxxxX-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
(9XX,13XX,14XX)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9XX,13XX,14XX)-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxx-3-[4-(X-xxxxxxxxxxxxxxx)4-(xxxxxxxxxxxxxxx)]xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{4-(xxxxxxxxxxxxx)-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-[(1X,2X)-3-(xxxxxxxxxxxxx)-1-xxxxx-2-xxxxxxxxxxxx]xxxxx |
|
|
Xxxxxxx |
4,5α-xxxxx-3,6-xxxxxxxxx-17-xxxxxxxxxxxxxxx-6,8-xxxx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-3-xxxxxxx-17-xxxxxXxxxxxx-6-xx-6-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
X-{1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxx |
xxxxx-(1XX,2XX)-2-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-3-xx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-4-xxxxx-4-(1,2,5-xxxxxxxxxxxxxxxxxx-4-xx)xxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx v xxxxx xxxxxxx, xxxx xxxxxx x xxxxxx omamných xxxxx uvedených v xxxxx xxxxxxx a xxxx omamných xxxxx xxxxxxxxx x tomto xxxxxxx xxxxxx xxxx xxxxxxx, xxxxxx x xxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxx xxxxx existovat.
Příloha x. 2 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx xxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx existovat.
Příloha x. 3 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 3 omamných xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx název (XXX) v xxxxxx xxxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
| Xxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxx | |
| Xxxxxxxxxxxxxxxx | X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxx-2-xxxxxx | |
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxx |
[5X,6X,7X,14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx- 17-methyl-6,14-ethenomorfinan-3-ol |
|
|
Heroin |
(5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát |
|
|
Ketobemidon |
1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on |
|
|
Konopí |
S xxxxxxxx xxxxxx xxx léčebné xxxxxxx uvedené x xxxxxxx x. 1 |
|
|
Pryskyřice x konopí |
Včetně xxxx xxxxxxxx látek xxxxxxxxx x této xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx soli xxxxx xxxxxxxxx.
Xxxxxxx x. 4 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
|
Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx další xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
XX-XXXXXXXX |
X-[(1X)-1 -(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
Xxxxxxxxxx |
|
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxx xxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-7921 |
3,4-xxxxxxx- X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
|
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-XXXXXXXX |
XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
XXX-XXXXXX |
Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXX |
XXX-001, 2NE1 |
N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid |
|
|
APINACA |
N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid |
AKB48 |
|
|
bk-PMA |
2-amino-1-(4-methoxyfenyl)propan-1-on |
||
|
Methedron |
bk-PMMA |
1-(4-methoxyfenyl)-2-(methylamino)propan-1-on |
|
|
BMDP |
3,4-MDBC |
2-benzylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
|
2-Brommethkathinon |
2-BMC |
(RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on |
|
|
3-Brommethkathinon |
3-BMC |
(RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on |
|
|
4-Brommethkathinon |
4-BMC |
(RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on |
Brefedron |
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
|
25I-NBOH |
2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol |
2C-I-NBOH; Cimbi-27 |
|
|
25I-NBOMe |
2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
NBOMe-2C-I |
|
|
Bromo-Dragonfly |
(2R)-1-(4-bromfuro[2,3-f][1]benzofuran-8-yl)propan-2-amin |
||
|
Butylon |
Bk-MBDB |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on |
B1 |
|
2-Chloramfetamin |
2-CA |
1-(2-chlorfenyl)propan-2-amin |
|
|
3-Chloramfetamin |
3-CA |
1-(3-chlorfenyl)propan-2-amin |
|
|
4-Chloramfetamin |
4-CA |
1-(4-chlorfenyl)propan-2-amin |
PCA |
|
4-Chlor-N-butylkathinon |
4-CBC |
2-(butylamino)-1-(4-chlorfenyl)propan-1-on |
4-Chlorbutylkathinon |
|
2-Chlorethkathinon |
2-CEC |
1-(2-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
3-Chlorethkathinon |
3-CEC |
1-(3-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Chlorethkathinon |
4-CEC |
1-(4-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Chlorisobutyrfentanyl |
4-Cl-iBF |
N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
|
2C-E |
2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin |
||
|
2-Chlormethamfetamin |
2-CMA |
1-(2-chlorfenyl)-N-methylpropan-2-amin |
|
|
3-Chlormethamfetamin |
3-CMA |
1-(3-chlorfenyl)-N-methylpropan-2-amin |
|
|
4-Chlormethamfetamin |
4-CMA |
1-(4-chlorfenyl)-N-methylpropan-2-amin |
p-CMA |
|
2-Chlormethkathinon |
2-CMC |
1-(2-chlorfenyl)-2-(methylamino)propan-1-on |
|
|
3-Chlormethkathinon |
3-CMC |
1-(3-chlorfenyl)-2-(methylamino)propan-1-on |
|
|
4-Chlormethkathinon |
4-CMC |
1-(4-chlorfenyl)-2-(methylamino)propan-1-on |
Clefedron |
|
2-Chlorpentedron |
2-CPD |
1-(2-chlorfenyl)-2-(methylamino)pentan-1-on |
|
|
3-Chlorpentedron |
3-CPD |
1-(3-chlorfenyl)-2-(methylamino)pentan-1-on |
|
|
4-Chlorpentedron |
4-CPD |
1-(4-chlorfenyl)-2-(methylamino)pentan-1-on |
|
|
4-Chlor-α-pyrrolidinovalerofenon |
4-Cl-α-PVP |
1-(4-chlorfenyl)-2-(pyrrobdin-1-yl)pentan-1-on |
|
|
CUMYL-4CN-BINACA |
SGT-78 |
1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3 -xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx-2-xxxxx fentanyl |
N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
|
Despropionyl-4-fluor xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
|
Diethyltryptamin |
DET |
N,N-diethyl-N-[2-(indol-3-yl)ethyl]amin |
|
|
Difenidin |
DPD; 1,2-DEP; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; MBPV |
1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
Dimethoxyamfetamin |
DMA |
(2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin |
|
|
p-Methyl-4-methylaminorex |
4,4'-DMAR |
4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin |
p4-DMAR |
|
Dimethylheptyltetrahydrokanabinol |
DMHP |
3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol |
|
|
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
3,4-Dimethylmetkathinon |
3,4-DMMC |
1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
Dimethyltriptamin |
DMT |
N-[2-(indol-3-yl)ethyl]- X,X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- methylkathinon |
|
Methkathinon |
Efedron |
(2RS)-1-fenyl-2-(methylamino)propan-1-on |
|
|
Ephylon |
MDEVP; bk-EBDP |
1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on |
N-ethyl-pentylon |
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindol-[4,3-fg]chinolin-9-karboxamid |
||
|
Etizolam |
AHR 3219; Depas |
4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][ 1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxxxxxx |
(XX)-xxxxx-2-xxxxx-2-xxxxxxxxx-2-xxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
x-xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
5X-XXX |
Xxxxxx-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
5X-XXX |
|
Xxxxxxxx xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1 -(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, o-FF |
|
3-Fluorfentanyl |
Metafluorfentanyl |
N-(3-fluorfenyl)-N-[1 -(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
4F-TMP |
|
4-Fluorpentedron |
4-FPD; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx ester xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
|
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
|
Xxxxxxxxxxxxxxx |
XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
2-xxxxxxxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxx xxxxxxxxx |
4-XX-XXX |
3-{2-[xxxxx(xxxxxx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxx; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
(xxx)Xxxxxxx-X-xxxxxxxx X-xxxxxx xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -yl)methanon |
||
|
JWH-250 |
2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on |
||
|
JWH-398 |
(4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3 -xx)xxxxxxxx |
||
|
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx lysergové; (6xX,9X)- X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- - 6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
|
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxx |
xx-XXXX |
2-xxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX-XXXXXX |
X-[[1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx]-3-xxxxxx-xxxxx, xxxxxx xxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XxX-XXX |
5-xxxxxxx-x-xxxxxxxxxxxxxxx |
||
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3-Xxxxxxxxxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
α-Xxxxxxxxxxxxxx xxxxxxxxx analog |
BF; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3 -xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
|
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
XX8, α-PHPP |
1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on |
||
|
PV9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
|
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
X6x(10x)-, X6x(7)-, X7-, X8-, X10-, D9(11)-tetrahydrokanabinoly x xxxxxx xxxxxxxxxxxxx |
|
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-51,754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]- X-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx xxxxxx |
|
|
X-15 |
4-xxxxx-X-(1-xxxxxxxxxxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
||
|
X-18 |
4-xxxxx-X-(1-[2-(4-xxxxxxxxxx)xxxxx]-xxxxxxxxx-2-xxxxxx)xxxxxxxxxxxxxxxx |
Xxxxxx stereoizomerů xxxxxxxxxxxxxx látek, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx mohou existovat xxxxx zvláštního xxxxxxxxxx xxxxxxxx a solí xxxxxxxxxxxxxx xxxxx xxxxxxxxx x tomto seznamu xx všech případech, xxx mohou xxxxxxxxx.
Xxxxxxx x. 5 x nařízení xxxxx x. 463/2013 Xx.
Xxxxxx x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) amino]heptanová |
||
|
Buprenofin |
(2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx butan-2-ol |
||
|
Bromdimethoxyfenethyl xxxx |
2X-X |
(4-xxxx-2,5-xxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxxx |
(2X)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxx |
XXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxx |
7-(2-{[(2XX)-1-xxxxxxxxxxx-2-xx]xxxxx}xxxxx)-1,3-xxxxxxxx-7X- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-hydroxybutanová |
||
|
Levamfetamin |
(2RS)-1-fenylpropan-2-amin |
||
|
Levmetamfetamin |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
| Lisdexamfetamin | (2S)-2,6-diamino-N-[(2S)-1-fenylpropan-2-yl]hexanamid | ||
|
Meklochalon |
3-(2-chlorfenyl)-2-methyl-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metachalon |
2-rnethyl-3-(2-methylfenyl)-1,2-dihydrochinazolin-4(3H)-on |
||
|
Metamfetamin |
(2S)-1-fenyl-N-methylpropan-2-amin |
||
|
Metamfetamin racemický |
(2RS)-1-fenyl-N-methylpropan-2-amin |
||
|
Methylfenidát |
methyl-(2RS)-2-fenyl-2-[(2RS)-piperidin-2-yl]acetát |
||
|
Sekobarbital |
kyselina 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) a xxxx xxxxxxxxxxxxx |
xxxx. (-)-trans-Δ9-THC |
|
Zipeprol |
(2RS)-1-fenyl-1-methoxy-3-[4-(2-methoxyfenethyl)piperazin-1-yl] xxxxxx-2xx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx existence xxxxxxxx solí xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 6 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) v xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- xxxxxxxxx-2,6-xxxxxxx-3-xxxxxxxxxx-8-xx |
||
|
Xxxxxxxxxxxxx |
xxxxxxxx 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx látek xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx takových xxxx je možná.
Příloha č. 7 x nařízení vlády x. 463/2013 Sb.
Seznam x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx obecný xxxxx |
Xxxxxxxx xxxxx podle XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx kyselina |
||
|
Alprazolam |
8-chlor-6-fenyl-1-methyl-4H.[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
|
Amfepramon |
2-(diethylamino)-1-fenylpropan-1-on |
||
|
Aminorex |
5-fenyl-4,5-dihydrooxazol-2-amin |
||
|
Barbital |
5,5-diethylbarbiturová kyselina |
||
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethyl)-N-methylamin |
||
|
Benzylpiperazin |
1-benzylpiperazin |
||
|
Bromazepam |
7-brom-5.(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin |
||
|
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3- karboxylát |
||
| Fenazepam | 7-bromo-5-(2-chlorofenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
|
Fendimetrazin |
(2S,3S)-2-fenyl-3,4-dimethylmorfolin |
||
|
Fenkamfamin |
(±)-2-(ethylamino)-3-fenylbicyklo[2.2.1]heptan |
||
|
Fenobarbrial |
5-ethyl-5-fenylbarbiturová kyselina |
||
|
Fenproprex |
(±)-1-fenyl-2-[(2-kyanethyl)amino]propan |
||
|
FIudiazepam |
7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2G-1,4-benzodiazepin-2-on |
||
|
FIurrazepam |
7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-bezodiazepin- 2-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx -6(5X)-xx |
||
|
Xxxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxXxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxx karbamát |
||
|
Ketamin |
(2RS)-2-(2-chlorfenyl)-2-(methylamino)cyklohexan-1-on |
||
|
Ketazolam |
11-chlor-12b-fenyl-2,8-dimethyl-8,12b-dihydro-4H-[1,3]oxazino[3,2-d][1,4] xxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxx-2,4(3X,5X]-xxxx |
||
|
Xxxxxxxxxx |
5-{2-xxxxxxxxxX}-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx--2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X- xxxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2 -on |
||
|
Mazindol |
5-(4-chlorfenyl)-2,5-dihydro-3H-imidazo[2,1-α]-isoindol-5-ol |
||
|
Medazepam |
7-chlor-5-fenyl-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin |
||
|
Mefenorex |
(±)-2-[(3-chlorpropyl)amino]-1-fenylpropan |
||
|
Meprobamát |
2-methyl-2-propylpropan-1,3-diyl-dikarbamát |
||
|
Mesokarb |
N-(fenylkarbamoyl)-3-(2-fenyl-1-methylethyl)sydnonimin |
||
|
Methylfenobarbital |
5-ethyl-5-fenyl-1-methylbarbiturová kyselina |
||
|
Methyprylon |
3,3-diethyl-5-methylpiperidin-2,4-dion |
||
|
Midazolam |
8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazol[1,5-α][1,4]bezodiazepin |
||
|
Nimetazepam |
5-fenyI-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nitrazepam |
5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Nordazepam |
7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazepalll |
7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Oxazalant |
10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydroozazolo[3,2-d][1,4] xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxX-2-xxxxx-1,3 -xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxxx-4-xxxxx-1-(xxxx-2-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxX(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-α][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxxx[1,2-α]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx solí xx xxxxx.
Xxxxxxx x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 xxxxxxxxx xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx nebo xxxx xxxxxxx xxxxx (xxxxxxx xxxx xxxxxxxx) x xxxxxxxx xxxxxx látky |
|
|
a) |
v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, příp. x jiné xxxxxx xxxxx xxxxx přesáhnout 100 mg, |
||
|
b) |
v xxxxxxx xxxxx xxx koncentrace xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, příp. v xxxx lékové xxxxx 0,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 5 % x xxxxxxxx difenoxylátu v xxxxx tabletě, xxxxxx, xxxxxx, xxxxx, xxxx. xxxx lékové xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx musí xxx nejméně 1 % k xxxxxxxx xxxxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx lékové xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx přesáhnout 135 xx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx formě. |
||
|
b) |
v xxxxxxx xxxxx být xxxxxxxxxxx xxxxx než 2,5 %. |
||
|
Xxxxxxxxx xxxxx xxxxxxxxx žádnou xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx kokainu xxxxx xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx nesmí přesáhnout 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx xxxxx xxxx xxxx dalších látek (xxxxxxx xxxx xxxxxxxx). |
||
|
Xxxxxx xxxxx x xxxxxxxxx xxxxxxxx xxxxx xxx xxxxxx xxxxxxx xxxx x xxxxxxx xxxxxxxx, xxx ohrozila xxxxxxx xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx xxxxxx x xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx xxx xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx nebo xxxx xxxxxxx látek (nikoliv xxxx xxxxxxxxx) xxxxx xxx nižší než 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx nesmí xxxxxxxxxx 100 mg x xxxxx tabletě, xxxxxxx, xxxxxx, xxxxx, xxxx. v xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxx xxxx xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
||
Xxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx xx xxxxx xxx X4 nebo XX2.
Čl. II
Toto xxxxxxxx xxxx oznámeno v xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx xxxxxxx xxxxxxxxx x. 46/2017 Sb. x účinností xx 1.3.2017
Xx. XX
Xxxx nařízení xxxx oznámeno x xxxxxxx se směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx a xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 30/2018 Xx. x účinností od 8.3.2018
Xx. XX
Xxxx nařízení xxxx xxxxxxxx x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Xx. x xxxxxxxxx od 25.10.2018
Právní předpis x. 463/2013 Xx. xxxxx xxxxxxxxx xxxx 1.1.2014.
Ve xxxxx tohoto xxxxxxxx xxxxxxxx xxxx podchyceny xxxxx a xxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx x.:
243/2015 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx
x účinností xx 1.10.2015
46/2017 Xx., xxxxxx xx mění xxxxxxxx xxxxx x. 463/2013 Sb., o xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxx xxxxx x. 243/2015 Xx.
x účinností xx 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx účinnosti 1.5.2017
30/2018 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x účinností xx 8.3.2018
242/2018 Sb., xxxxxx se xxxx xxxxxxxx xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2022
228/2023 Sb., xxxxxx xx mění xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 1.8.2023
52/2024 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx se mění xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2024 x 1.1.2025
419/2024 Xx., xxxxxx xx xxxx xxxxxxxx vlády x. 463/2013 Sb., x xxxxxxxxx návykových xxxxx, xx znění xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.1.2025 x 1.4.2025
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x odkazech xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx právního xxxxxxxx.
1) Xxxxxxxx xxxxxx x omamných xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx xxxxx Protokolu x xxxxxxx Xxxxxxxx xxxxxx o xxxxxxxx xxxxxxx, vyhlášeného xxx č. 458/1991 Sb.
2) Úmluva o xxxxxxxxxxxxxx látkách, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX xx xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx minimální xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x sankcí x xxxxxxx xxxxxxxxxxxx xxxxxxx s xxxxxxx.
Xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx xx xxxx xxxxxxx xxxxxxxxxx Xxxx 2004/757/SVV x xxxxx xxxxxxxx xx xxxxxxxx xxxxx xxxx psychoaktivní xxxxx x xxxxxxx xxxxxxxxxx Xxxx 2005/387/XXX.